首页> 外文期刊>The Australian and New Zealand journal of psychiatry >The rise and fall of ADHD child prescribing in Western Australia: Lessons and implications
【24h】

The rise and fall of ADHD child prescribing in Western Australia: Lessons and implications

机译:西澳大利亚州多动症儿童处方药的兴衰:教训和启示

获取原文
获取原文并翻译 | 示例
           

摘要

From 1989 to 2000 the number of Western Australians prescribed stimulant medication grew twenty-threefold. By 2000 there were 20,648 Western Australians on prescription stimulants. The Western Australia (WA) Health Department estimated 85% to 90% (17,551 to 18,583) were children. This represented 4.2% to 4.5% of all WA children aged between 4-17 years (Department of Health, 2002). All through this period WA was the highest per capita prescribing Australian state or territory and in 2000 exceeded the USA national rate (Berbatis et al., 2002). By 2003 the number of Pharmaceutical Benefits Scheme (PBS) per capita Attention Deficit Hyperactivity Disorder (ADHD) prescriptions in WA was approximately three and a half times the Australian average (Whitely, 2010). There is limited data available, however, it appears the disproportionate rates were due both to higher per capita patient rates and higher than average doses.
机译:从1989年到2000年,西澳大利亚人开出的兴奋剂处方数量增加了23倍。到2000年,有20,648名使用处方兴奋剂的西澳大利亚人。西澳大利亚州卫生部估计有85%至90%(17,551至18,583)为儿童。这占所有4-17岁西澳州儿童的4.2%至4.5%(卫生部,2002年)。在此期间,西澳州是规定澳大利亚州或领地的最高人均收入,并在2000年超过了美国的国民比例(Berbatis等,2002)。到2003年,西澳大利亚州的人均注意力缺陷多动障碍(ADHD)处方药受益计划(PBS)数量约为澳大利亚平均水平的三倍半(Whitely,2010年)。可用的数据有限,但是,似乎不相称的比率是由于人均患者比率较高和高于平均剂量所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号